Autonomous drone successfully delivers temperature-controlled drugs in test programme
July 17, 2019Research and Development, Sales and Marketing Drones, humanitarian aid, pharma
A humanitarian consortium has successfully completed a testing programme for the delivery of temperature-controlled medicines via the use of unmanned …
NICE greenlights Novartis Kisqali combo in HR+/HER2- advanced breast cancer
July 17, 2019Manufacturing and Production, Medical Communications, Research and Development Cancer, Kisqali, NICE, Novartis, UK, breast cancer, pharma
Novartis’ Kisqali (ribociclib) has secured recommendation from NICE in combination with fulvestrant, meaning the cyclin-dependent kinase 4 and 6 (CDK4/6) …
Roche signs deal with Skyhawk over molecules that modulate RNA splicing
July 17, 2019Research and Development Genentech, Roche, Skyhawk, drug development, rna splicing
Roche’s Genentech unit has signed a deal with Massachusetts-based firm Skyhawk Therapeutics to develop and commercialise small molecules that modulate …
Genentech signs $1 billion deal with Sosei over GCPRs
July 17, 2019Research and Development Genentech, Roche, gcprs, pharma, sosei
Roche’s Genentech has entered into a partnership with Sosei Heptares to develop small molecules and biologics that G protein-coupled receptor …
AstraZeneca to switch entire fleet to electric vehicles by 2030
July 17, 2019Research and Development AstraZeneca, EV100, electric vehicles, environmentalism, pharma, renewables
AstraZeneca has revealed plans to use only electric vehicles by 2030. In joining the EV100 group, AstraZeneca will transfer the …
Bayer’s Gadavist becomes first FDA-approved drug for MRI in coronary artery disease patients
July 16, 2019Manufacturing and Production, Sales and Marketing Bayer, FDA, Gadavist, coronary artery disease, pharma
The FDA has awarded approval to Bayer’s Gadavist (gadobutrol) injection, the company confirmed.
Capricor’s share price rockets up by 150% on Phase 2 Duchenne muscular dystrophy success
July 16, 2019Manufacturing and Production, Research and Development CAP-1002, Capricor Therapeutics, Duchenne Muscular Dystrophy, pharma
Capricor Therapeutics has unveiled impactful new Phase 2 data for its investigational allogeneic cardiosphere-derived cell therapy CAP-1002 in the treatment …
Oklahoma lawyers say J&J is kingpin of pharmaceutical cartel
July 16, 2019Manufacturing and Production J&J, JJ, Oklahoma, opioid crisis, opioids, pharma
Lawyers representing the State of Oklahoma described Johnson & Johnson as the ‘kingpin’ in a ‘pharmaceutical cartel’ as they accused …
GSK teams up with Strathclyde and University of Nottingham
July 16, 2019Manufacturing and Production GSK, GlaxoSmithKline, UK, britain, pharma, universities
GlaxoSmithKline has teamed up with the University of Nottingham and the University of Strathclyde for a five-year partnership aimed at …
Boehringer buys cancer vaccine company AMAL Therapeutics for €325 million
July 16, 2019Manufacturing and Production AMAL Therapeutics, Boehringer Ingelheim, Geneva, cancer vaccines, oncology
Boehringer Ingelheim has bought Swiss biotech AMAL Therapeutics, a company focused on cancer immunotherapy and cancer vaccines. AMAL’s lead candidate, …
Darius Hughes, Head of Vaccines Business Unit UK, Pfizer
July 15, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Darius Hughes, Pfizer, Working Life, biotech, pharma, vaccines
“Vaccines provide a unique opportunity to have a positive effect on hundreds of thousands of people” – Darius Hughes, Head …
FDA and EMA fully implement mutual recognition agreement between US and EU
July 15, 2019Sales and Marketing EMA, FDA, GMP, Slovakia, mra, mutual recognition, pharma
The FDA has recognised Slovakia’s ability to carry out inspections of manufacturing facilties. The recognition of Slovakia marks the full …
AstraZeneca’s Farxiga fails to get FDA approval for patients with Type 1 diabetes
July 15, 2019Sales and Marketing AstraZeneca, EMA, FDA, US, diabetes, farxiga
The FDA had said it will not approve AstraZeneca’s diabetes drug Farxiga for use as a supplement to insulin in …
GSK’s Zejula meets primary endpoint in Phase 3 trial of patients with ovarian cancer
July 15, 2019Sales and Marketing
British multinational GlaxoSmithKline has said ovarian cancer drug Zejula (niraparib) met its primary endpoint in a Phase 3 trial. Zejula …
Gilead invests $5.1 billion into Galapagos NV
July 15, 2019Sales and Marketing Galapagos, Gilead, biotech, collaboration, deal, drug discovery, pharma
Gilead has entered into a 10 year partnership with Belgo-Dutch biotech Galapagos NV. The collaboration will see Gilead invest $5.1 …
Generex Biotechnology acquires Medisource Partners
July 15, 2019Sales and Marketing Generex, Medisource, medical supplies, medicines, pharma, surgery
Canadian firm Generex Biotechnology has acquired Texas-based medical and surgical products distributor Medisource Partners. Under the terms of the deal …
AstraZeneca’s Imfinzi gets orphan drug designation from FDA
July 12, 2019Medical Communications AstraZeneca, Cancer, Imfinzi, lung cancer, pharma
AstraZeneca’s cancer immunotherapy Imfinzi has been granted orphan drug status as a treatment for small cell lung cancer (SCLC). The …
Top Ten most popular articles on Pharmafile.com this week!
July 12, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, HPV, NHS, NICE, Novartis, Pfizer, Trump, pharma, vaccines
This week’s most popular story covered news of Trump’s claims that he will introduce an executive order to ensure the …
Bernie Sanders to join trip to Canada for cheaper insulin
July 12, 2019Medical Communications
Senator Bernie Sanders is set to join people with Type 1 diabetes on a trip to Canada in search of …
Novartis and Amgen halt trials into Alzheimer’s drug after patients get worse
July 12, 2019Medical Communications Alzheimer's, Amgen, Banner Alzheimer's Institute, Novartis, dementia, pharma, research
Novartis, Amgen and Banner Alzheimer’s Institute have dropped a study into investigational Alzheimer’s drug CNP520 (umibecestat) after some patient’s conditions …
Latest content
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
